EP0236140A2 — Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
Assigned to Otsuka Pharmaceutical Co Ltd · Expires 1987-09-09 · 39y expired
What this patent protects
Carbostyril derivatives or salt thereof, including novel compounds, having activities for curing and/or improving arrhythmia. Some carbostyril devitavies having similar chemical structural formula to those of carbostyril derivatives of the present invention are known in the…
USPTO Abstract
Carbostyril derivatives or salt thereof, including novel compounds, having activities for curing and/or improving arrhythmia. Some carbostyril devitavies having similar chemical structural formula to those of carbostyril derivatives of the present invention are known in the prior art references, however, above-mentioned parmacological activities have not been known yet.
Drugs covered by this patent
- Oxbryta (voxelotor) · Global Blood Theraps
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.